Citizens Financial Group Inc. RI bought a new position in Atrion Co. (NASDAQ:ATRI - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 2,941 shares of the medical instruments supplier's stock, valued at approximately $1,114,000. Citizens Financial Group Inc. RI owned approximately 0.17% of Atrion at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Boston Trust Walden Corp grew its holdings in shares of Atrion by 4.8% in the fourth quarter. Boston Trust Walden Corp now owns 35,091 shares of the medical instruments supplier's stock worth $13,292,000 after acquiring an additional 1,609 shares during the period. Exchange Traded Concepts LLC bought a new stake in shares of Atrion in the third quarter worth $333,000. WINTON GROUP Ltd bought a new stake in shares of Atrion in the third quarter worth $208,000. First Financial Corp IN bought a new stake in shares of Atrion in the fourth quarter worth $136,000. Finally, SG Americas Securities LLC bought a new stake in shares of Atrion in the fourth quarter worth $108,000. Institutional investors own 66.19% of the company's stock.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded Atrion from a "hold" rating to a "sell" rating in a research report on Monday, April 22nd.
Check Out Our Latest Analysis on ATRI
Atrion Stock Performance
Shares of Atrion stock traded down $3.96 during trading hours on Friday, hitting $395.01. The company's stock had a trading volume of 26,395 shares, compared to its average volume of 29,758. The business has a 50 day moving average price of $406.12 and a two-hundred day moving average price of $364.66. Atrion Co. has a 12-month low of $274.98 and a 12-month high of $625.00. The company has a market cap of $695.22 million, a PE ratio of 35.81 and a beta of 0.60.
Atrion (NASDAQ:ATRI - Get Free Report) last released its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $3.65 earnings per share (EPS) for the quarter. The business had revenue of $43.58 million for the quarter. Atrion had a return on equity of 8.07% and a net margin of 11.46%.
Atrion Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were given a dividend of $2.20 per share. This represents a $8.80 annualized dividend and a dividend yield of 2.23%. The ex-dividend date was Thursday, March 14th. Atrion's dividend payout ratio is currently 79.78%.
Atrion Company Profile
(
Free Report)
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.
Featured Stories
Before you consider Atrion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atrion wasn't on the list.
While Atrion currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
